On March 6, 2018, the Board of Directors (the “Board”) of Rennova Health, Inc. (the “Company”), based on the recommendation of the Compensation Committee of the Board, approved grants to employees and directors of an aggregate of 71,333,331 shares of common stock, including the following to the directors of the Company:
Seamus Lagan 26,666,667 shares Dr. Kamran Ajami 3,333,333 shares John Beach 3,333,333 shares Gary L. Blum 3,333,333 shares Christopher Diamantis 3,333,333 shares Trevor Langley 3,333,333 shares ------------------------------- 43,333,332 ? doesn't add up to 71,333,331
After accounting for the grants of shares to employees and directors of the Company and additional conversions of certain convertible securities of the Company, there were 488,097,654 shares of common stock issued and outstanding as of March 7, 2018. The Company is authorized to issue 500,000,000 shares of common stock
News 
Market Data 
Discover 
